SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03
Published August 19, 2026 · Recall initiated: July 29, 2026
Summary
FDA records drug Class II recall D-0754-2026, published August 19, 2026 and initiated July 29, 2026. Recalling firm: Apollo Care, LLC; Status: Ongoing; Reported quantity: 250 vials.; Lot: Lot: AC-017272, Exp. 12/12/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Apollo Care, LLC
- Distributor
- Nationwide within the U.S
- Lot
- Lot: AC-017272, Exp. 12/12/2026.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLOAugust 19, 2026
- FDASEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only,August 19, 2026
- FDASEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only,August 19, 2026
- FDASEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLOAugust 19, 2026
- FDASEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, ForAugust 19, 2026
- FDASEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For SubcutaneousAugust 19, 2026
Questions about this recall
Was SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03 recalled?
Yes. FDA published recall D-0754-2026 on August 19, 2026. Reported hazard: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail